BMRN FY 2016 Earnings — BioMarin Pharmaceutical Inc. Revenue & Financial Results | Market Cap Arena

BMRNBioMarin Pharmaceutical Inc.

$12B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.1B+25.5% YoY

Gross Profit

$907M81.2% margin

Operating Income

-$803M-71.9% margin

Net Income

-$630M-56.4% margin

EPS (Diluted)

$-3.79

Cash Flow

Operating Cash Flow

-$228M

Free Cash Flow

-$376M

Stock-Based Comp.

$135M

Balance Sheet

Total Assets

$4.0B

Total Liabilities

$1.3B

Stockholders' Equity

$2.8B

Cash & Equivalents

$408M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$890M	+25.5%
Gross Profit	$907M	$738M	+23.0%
Operating Income	-$803M	-$111M	-625.8%
Net Income	-$630M	-$172M	-266.8%